Try our Advanced Search for more refined results
Melinta Therapeutics Inc.
-
Order | Filed: May 31, 2024 | Entered: May 31, 2024 KAY v. MELINTA THERAPEUTICS LLC
Civil Rights: Jobs | New Jersey
Order ~Util - Set Hearings
TEXT ORDER: For the Initial Scheduling Conference scheduled for June 17, 2024, at 2:30 p.m., see ECF No. 16 , please dial 973-437-5535 and enter Phone Conference ID 211 334 228#. So Ordered by Magistrate Judge Jose R. Almonte on 5/31/2024. (akw, )
-
Filed: May 24, 2024 | Entered: May 24, 2024 Melinta Therapeutics, LLC et al v. Nexus Pharmaceuticals, Inc.
835 Patent - Abbreviated New Drug Application(ANDA) | Illinois Northern
Status
STATUS Report by Nexus Pharmaceuticals, Inc.
(Wallace, Joel) (Entered: 05/24/2024) -
Order | Filed: May 23, 2024 | Entered: May 24, 2024 KAY v. MELINTA THERAPEUTICS LLC
Civil Rights: Jobs | New Jersey
Order ~Util - Set Hearings
LETTER ORDER Pursuant to Local Civil Rule 16.1. On June 17, 2024, at 2:30 p.m. you shall participate in an initial scheduling conference before U.S Magistrate Judge Jose R. Almonte. The conference will be held telephonically. Signed by Magistrate Judge Jose R. Almonte on 5/23/2024. (qa, )
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Archive of over 450,000 articles
- Database of over 2.1 million cases
- 62,000+ organization-specific pages.
- Daily and real-time news and case alerts on organizations, industries, and customized search queries.
- Significant legal events involving law firms, companies, industries, and government agencies.
- Learn more
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login